During this year´s AACR Annual Meeting, Washington DC, April 6 -10, ecancer caught up with VHIO´s Laura Soucek, PI of the Mouse Models of Cancer Therapies Group, to discuss her group´s pioneering work on Myc inihibition in pre-clinical mouse models.
Related Posts
“We are one of the few groups in Europe to provide a pre-screening program of mutations in patients who are candidates for phase I clinical trials": VHIO communications interviews Ana Vivancos
An interview with Ana Vivancos, Principal Investigator of VHIO´s Cancer Genomics Group “We are one of the few groups in…
25 Feb 2014
European cancer centers of excellence: powering long-term collaborative partnerships.
For many decades, cancer research in Europe has been heavily fragmented, inefficient and duplicating work. Now, long-term collaborations have been…
11 Dec 2015
Molecular Study Confirms 4 Different HER2+ Breast Cancer Subtypes
Latest research at VHIO confirms 4 subgroups of HER2+ breast cancer with different molecular characteristics The diagnostic test for these…
09 Sep 2014
VHIR´s Health Innovation Contest 2015: first place goes to Myc Inhibitory Peptide
Barcelona, 17 July 2015. – Last week, 10 July, marked the second Vall d´Hebron Research Institute (VHIR) Health Innovation Contest,…
20 Jul 2015
Princess Margaret Cancer Centre, Vall d’Hebron Institute of Oncology partner to advance personalized cancer medicine
Source: Princess Margaret Cancer Centre TORONTO, Canada – Feb. 27, 2015 – Two internationally acclaimed cancer centres today announced a…
28 Feb 2015
Oncology channel ecancerTV catches up in Chicago with VHIO´s Rodrigo Dienstmann and Enriqueta Felip
During this year´s Annual Meeting of the American Society of Clinical Oncology (ASCO), that came to a close yesterday in…
08 Jun 2017
ecancer catches up with VHIO´s Paolo Nuciforo during the 2015 WIN Symposium
During last month´s WIN – Worldwide Innovative Networking in personalized cancer medicine, Symposium, June 29 – 30, Paris, France, ecancer…
07 Jul 2015
Call Now Open: Applications for Oncology Research Fellowship (2) at the Mass General Hospital Cancer Center, USA
CALL FOR APPLICATIONS 2012 The objective of the Fellowship is to provide support to two outstanding MD’s, PhD’s, or MD/PhD’s…
16 Apr 2012
Gene-panel sequencing spurs improved diagnosis of hereditary cancer
Between 50 – 75% of the most common hereditary cancers (breast and colon) escape the diagnostic ´lens´ when only factoring…
02 Nov 2015
Launched: VHIO´s Schools and Science Education Programme
VHIO opens its doors to bright young minds to learn about cancer research and discover science as a career path…
18 Oct 2017
Nature Reviews Cancer Perspectives/Opinion article: an exploration of the precise and predictive powers of PDX models – now and in the future
In a recent Perspectives/Opinion article* published online in Nature Reviews Cancer, members of the EurOPDX Consortium, including VHIO´s Joaquín Arribas,…
16 Feb 2017
DUE TO POPULAR DEMAND ADDITIONAL GIG ON 20 DECEMBER – Jarabe de Palo´s Pau Donés: singing to support crucial research into novel therapies against colorectal cancer
IMPORTANT NOTIFICATION: As an update to this earlier news item (see below), Pau´s fundraising concert on the 22nd December is…
23 Nov 2015
The Translational Biomedicine and Oncology Research Consortium has been created
It is the first National Agreement that includes the Academic environment, basic research, clinical research and the pharmaceutical industry
07 Sep 2010
VHIO: supporting the interests of upcoming young talents in medical oncology
While the ever-advancing landscape of precision medicine in oncology undoubtedly brings fresh hope for patients, it also poses many yet…
27 Jul 2016
Driving a novel therapy against glioblastoma: VHIO´s Laura Soucek awarded BBVA Foundation Grant to validate peptides targeting Myc
• The BBVA Foundation backs research aimed at preclinically validating recently reported findings that established Omomyc as a potential…
09 Oct 2015
